조직 증강용 충전 조성물
    2.
    发明公开
    조직 증강용 충전 조성물 有权
    用于组织补充的填充组合物

    公开(公告)号:KR1020120006451A

    公开(公告)日:2012-01-18

    申请号:KR1020110068627

    申请日:2011-07-11

    Abstract: PURPOSE: A filler composition for reinforcing tissue and a manufacturing method thereof are provided to be injected into biological tissue by being charged with injections easily to maintain the characteristic including viscoelasticity, and the like steadily after sterilization, and to enhance biocompatibility. CONSTITUTION: A filler composition for reinforcing tissue includes a hyaluronic acid of the following equation and a hydro gel of alkylendiamine crosslinking materials The equation is expressed as [HA]m-C(O)-NH-R1-NH-C(O)-[HA]n, wherein HA indicates the hyaluronic acid except a carboxyl group or its salt, R1 shows hydroxyl group, and C1-C6 indicate alkyl group, C3-C10 alkylene functional group which is substituted as C1-C6 alkoxy, or which is non-subjstituted, and m and n indicate integer ranged 10,000-4,000,000. The molecular weight of the hyaluronic acid is from 20,000 to 40,000 dalton.

    Abstract translation: 目的:提供一种用于增强组织的填充剂组合物及其制造方法,其通过在灭菌后容易地维持包括粘弹性等特性等特性的注射剂注入生物体组织,并提高生物相容性。 构成:用于增强组织的填充剂组合物包括以下等式的透明质酸和烷基二胺交联材料的水凝胶。该方程式表示为[HA] mC(O)-NH-R 1 -NH-C(O) - [HA ] n,其中HA表示除了羧基或其盐以外的透明质酸,R1表示羟基,C1-C6表示烷基,作为C1-C6烷氧基取代的C3-C10亚烷基官能团, 取代,m和n表示整数范围为10,000-4,000,000。 透明质酸的分子量为20,000至40,000道尔顿。

    가교결합성 히알루론산 유도체 제조방법 및 그 히알루론산유도체의 가교결합물

    公开(公告)号:KR101062320B1

    公开(公告)日:2011-09-05

    申请号:KR1020080074260

    申请日:2008-07-29

    Abstract: 본 발명은 가교결합성 히알루론산(hyaluronic acid, HA) 유도체 제조방법 및그 히알루론산 유도체의 가교결합물에 관한 것으로서, 더욱 상세하게는, 물-알코올 혼합용매 중에서 히알루론산 또는 그의 염 또는 유도체를 카르복실기 활성화제의 존재하에 지방족 디카르복실산의 디하이드라자이드 화합물과 반응시키는 단계를 포함하는 히알루론산 유도체 제조방법 및 이에 따라 제조된 히알루론산 유도체의 가교결합물에 관한 것이다. 본 발명에 따른 히알루론산 유도체의 가교결합물은 겔, 주름살 치료용 삽입물, 성형보조물, 관절염 치료용 삽입물, 약물 전달체 등의 다양한 생체적합성(biocompatibility) 소재로 사용될 수 있다.
    가교결합성, 히알루론산, 유도체, 가교결합물, 제조방법

    가교결합성 히알루론산 유도체 제조방법 및 그 히알루론산유도체의 가교결합물
    4.
    发明公开
    가교결합성 히알루론산 유도체 제조방법 및 그 히알루론산유도체의 가교결합물 有权
    制备可交联的羟丙酸衍生物和羟丙酸衍生物的交联产物的方法

    公开(公告)号:KR1020090013696A

    公开(公告)日:2009-02-05

    申请号:KR1020080074260

    申请日:2008-07-29

    CPC classification number: C08B37/0072 A61K47/36 A61L27/20 A61L27/54 C08J3/24

    Abstract: A method for preparing a crosslinkable hyaluronic acid derivative is provided to ensure excellent bio compatibility, high viscoelasticity and superior stability to a hyaluronidase, and to be used as various bio compatibility materials of gel, insert for treating wrinkle, molding subsidiary material, insert for treating arthritis and drug carrier. A crosslinkable hyaluronic acid derivative of the chemical formula 1: [HA]-C(O)-NHNH-C(O)-R^1-C(O)-NHNH2 is prepared by reacting a hyaluronic acid or their salt or derivative, with a dihydrazide compound of an aliphatic dicarboxylic acid represented by the following chemical formula 2: H2N-NH-C(O)-R^1-C(O)-NHNH2, in the water-alcohol mixed solvent, in the presence of a carboxyl group activating agent. In the formulae, [HA] shows a hyaluronic acid except for a carboxyl group or their salt or derivative, and R^1 shows substituted or unsubstituted C3-C10 alkylene radical.

    Abstract translation: 提供制备交联性透明质酸衍生物的方法,以确保优异的生物相容性,高粘弹性和对透明质酸酶的优异稳定性,并且用作凝胶的各种生物相容性材料,用于治疗皱纹的插入物,模制辅助材料,用于治疗的插入物 关节炎和药物载体。 化学式1:[HA] -C(O)-NHNH-C(O)-R 1 C(O)-NHNH 2的交联性透明质酸衍生物是通过使透明质酸或其盐或衍生物, 与由以下化学式2表示的脂族二羧酸的二酰肼化合物:在水 - 醇混合溶剂中,在水 - 醇混合溶剂中,在存在下列化学式2的情况下,将H 2 N-NH-C(O)-R 1 羧基活化剂。 在该式中,[HA]表示除羧基以外的透明质酸或其盐或衍生物,R 1表示取代或未取代的C 3 -C 10亚烷基。

    관절염 주사요법제
    6.
    发明公开
    관절염 주사요법제 审中-实审
    治疗注射剂治疗ARTHRITIS

    公开(公告)号:KR1020130028012A

    公开(公告)日:2013-03-18

    申请号:KR1020120099149

    申请日:2012-09-07

    CPC classification number: A61K9/0019 A61K31/728 A61K31/738 A61K47/36

    Abstract: PURPOSE: A therapeutic injection agent for arthritis is provided to ensure excellent physical property and long-term persistence. CONSTITUTION: A therapeutic injection agent for treating or relieving arthritis contains 0.4-3.0 (w/w)% of hydrogel which is prepared by crosslinking of hyaluronic acid and alkylene diamine. The alkylene diamine is hexamethylene diamine. The composition further contains hyaluronic acid.

    Abstract translation: 目的:提供用于关节炎的治疗注射剂,以确保优异的物理性能和长期持久性。 构成:用于治疗或缓解关节炎的治疗注射剂含有通过透明质酸和亚烷基二胺的交联制备的0.4-3.0(w / w)%的水凝胶。 亚烷基二胺是六亚甲基二胺。 组合物还含有透明质酸。

Patent Agency Ranking